Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Cancer incidence and mortality rates and trends in Trinidad and Tobago

Authors: Wayne A. Warner, Tammy Y. Lee, Kimberly Badal, Tanisha M. Williams, Smriti Bajracharya, Vasavi Sundaram, Nigel A. Bascombe, Ravi Maharaj, Marjorie Lamont-Greene, Allana Roach, Melissa Bondy, Matthew J. Ellis, Timothy R. Rebbeck, Simeon Slovacek, Jingqin Luo, Adetunji T. Toriola, Adana A. M. Llanos

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Cancer is the second leading cause of death in the Caribbean, including the islands of Trinidad and Tobago (TT). The population of TT consists of over 1.3 million people with diverse ancestral and sociocultural backgrounds, both of which may influence cancer incidence and mortality. The objective of this study was to examine incidence and mortality patterns and trends in TT.

Methods

Cancer surveillance data on 29,512 incident cancer cases reported to the Dr. Elizabeth Quamina Cancer Registry (population-based cancer registry of TT) between 1995 and 2009 were analyzed. Age-standardized rates, overall and by sex, ancestry, and geography, were reported.

Results

The highest incidence and mortality rates were observed for cancers related to reproductive organs in women, namely, breast, cervical, and uterine cancers, and prostate, lung and colorectal cancers among men. Average incidence rates were highest in areas covered by the Tobago Regional Health Authority (TRHA) (188 per 100,000), while average mortality rates were highest in areas covered by the North West Regional Health Authority (108 per 100,000). Nationals of African ancestry exhibited the highest rates of cancer incidence (243 per 100,000) and mortality (156 per 100,000) compared to their counterparts who were of East Indian (incidence, 125 per 100,000; mortality, 66 per 100,000) or mixed ancestry (incidence, 119 per 100,000; mortality, 66 per 100,000).

Conclusions

Our findings highlight the need for national investment to improve the understanding of the epidemiology of cancer in Trinidad and Tobago, and to ultimately guide much needed cancer prevention and control initiatives in the near future.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Valencia S, Brotons M, Mena M, Cosano R, Muñoz J et al: Human Papillomavirus and Related Diseases in Trinidad & Tobago Summary Report 2015-03-20 In, 2015.
4.
Ragin C, Edwards R, Heron DE, Kuo J, Wentzel E, Gollin SM, Taioli E. Prevalence of cancer-associated viral infections in healthy afro-Caribbean populations: a review of the literature. Cancer Investig. 2008;26(9):936–47.CrossRef
5.
6.
7.
8.
9.
10.
Pan American Health Organization (PAHO). PAHO/WHO country cooperation strategy, Trinidad and Tobago. Pan American Health Organization; 2006.
11.
Central Statistical Office (Trinidad and Tobago). Trinidad & Tobago 2011 Housing and Population Census, vol. 2017. Trinidad: Ministry of Planning and Development; 2017.
12.
The Central Statistical Office. Trinidad and Tobago 2011 Population and Housing Census Demographic Report. Trinidad and Tobago. Trinidad and Tobago Ministry of Planning and Sustainable Development; 2012.
13.
Pan American Health Organization (PAHO). Health in the Americas, Book 636. Washington, DC: Pan American Health Organization; 2012.
14.
Naraynsingh V, Hariharan S, Dan D, Bhola S, Bhola S, Nagee K. Trends in breast cancer mortality in Trinidad and Tobago--a 35-year study. Cancer Epidemiol. 2010;34(1):20–3.CrossRefPubMed
15.
Taioli E, Attong-Rogers A, Layne P, Roach V, Ragin C. Breast cancer survival in women of African descent living in the US and in the Caribbean: effect of place of birth. Breast Cancer Res Treat. 2010;122(2):515–20.CrossRefPubMed
16.
Naraynsingh V. Gastric carcinoma in the West Indies: a Trinidad study. Cancer. 1985;56(8):2117–9.CrossRefPubMed
17.
Luciani S, Cabanes A, Prieto-Lara E, Gawryszewski V. Cervical and female breast cancers in the Americas: current situation and opportunities for action. Bull World Health Organ. 2013;91(9):640–9.CrossRefPubMedPubMedCentral
18.
Warner WA, Morrison RL, Lee TY, Williams TM, Ramnarine S, Roach V, Slovacek S, Maharaj R, Bascombe N, Bondy ML, et al. Associations among ancestry, geography and breast cancer incidence, mortality, and survival in Trinidad and Tobago. Cancer Med. 2015;4(11):1742–53.CrossRefPubMedPubMedCentral
19.
Mutetwa B, Taioli E, Attong-Rogers A, Layne P, Roach V, Ragin C. Prostate cancer characteristics and survival in males of African ancestry according to place of birth: data from Brooklyn-New York, Guyana, Tobago and Trinidad. Prostate. 2010;70(10):1102–9.CrossRefPubMedPubMedCentral
20.
Jensen O, McLeannan R, Muir C, Skeet G. Cancer registration: principles and methods. IARC Sci Publ. 1991;95(17):p127-8.
21.
Boyle P, Parkin DM. Cancer registration: principles and methods. Statistical Methods for registries IARC Sci Publ. 1991;95:126–58.
22.
Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
23.
Segi M. Cancer mortality for selected sites in 24 countries (1950-1957): Sendai Department of Public Health. Tohoku University of Medicine; 1960.
24.
Segi M, Kurihara M. Cancer mortality for selected sites in 24 countries (1966-1967) vol. no 6. Nagoya: Japan Cancer Society; 1972.
25.
Team. RC: R. A language and environment for statistical computing. In: R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
26.
Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e1S–29S.CrossRefPubMedPubMedCentral
27.
Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008;25(9):2097–116.CrossRefPubMedPubMedCentral
28.
Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362(9387):847–52.CrossRefPubMed
29.
Wardwell NR, Massion PP. Novel strategies for the early detection and prevention of lung cancer. Semin Oncol. 2005;32(3):259–68.CrossRefPubMed
30.
Caribbean Epidemiology Centre (CAREC). Central Statistical Office (Trinidad and Tobago), Ministry of Health (Trinidad and Tobago), Pan American Health Organization (PAHO), University of the West Indies: Trinidad and Tobago Chronic Non-Communicable Disease Risk Factor Survey. Trinidad: Port-of-Spain; 2011.
31.
Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and Cancer--viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794–8.CrossRefPubMed
32.
Kyrgiou M, Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, Martin-Hirsch P, Tsilidis KK. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ. 2017;356:j477.CrossRefPubMedPubMedCentral
33.
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2224–60.CrossRefPubMedPubMedCentral
34.
Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386(10010):2287–323.CrossRefPubMed
35.
Bull FC, Armstrong TP, Dixon T. Physical inactivity. In: Ezzati M, Lopez AD, Rodgers A, CJL M, editors. Comparative Quantification of Health Risks: Global and Regional Burden of Diseases Attributable to Selected Major Risk Factors. Volume 847, EDN. World Health Organization; 2004.
36.
37.
Churpek JE, Walsh T, Zheng Y, Moton Z, Thornton AM, Lee MK, Casadei S, Watts A, Neistadt B, Churpek MM, et al. Inherited predisposition to breast cancer among African American women. Breast Cancer Res Treat. 2015;149(1):31–9.CrossRefPubMed
38.
Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR, Freedman ML, Rivers B, Green BL, Kumar N. Prostate cancer disparities in black men of African descent: a comparative literature review of prostate cancer burden among black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer. 2009;4(1):S2.CrossRefPubMedPubMedCentral
39.
Bunker CH, Patrick AL, Konety BR, Dhir R, Brufsky AM, Vivas CA, Becich MJ, Trump DL, Kuller LH. High prevalence of screening-detected prostate cancer among afro-Caribbeans: the Tobago prostate Cancer survey. Cancer Epidemiol Biomark Prev. 2002;11(8):726–9.
40.
Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013;2013:560857.CrossRefPubMedPubMedCentral
41.
Zeigler-Johnson CM, Spangler E, Jalloh M, Gueye SM, Rennert H, Rebbeck TR. Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes. Can J Urol. 2008;15(1):3872–82.PubMedPubMedCentral
42.
Daly B, Olopade OI. A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin. 2015;65(3):221–38.CrossRefPubMed
43.
IARC. Data comparability and quality. In: Forman D, Bray F, Brewster D, Gombe Mbalawa C, Kohler B, Pineros M, Steliarova-Foucher E, Swaminathan R, Lyon FJ, editors. Cancer Incidence in Five Continents Vol X. EDN, vol. 164. France: IARC Scientific Publication No; 2014.
44.
Warner WA, Martin DN, Lee TY, Badal K, Williams TM, Bajracharya S, Sundaram V, Bascombe NA, Maharaj R, Roach V, et al. Patterns of Cancer Incidence and Mortality Rates and Trends in Trinidad and Tobago. In: The 5th Annual Glob Health and Infectious Disease Conference, Science to Solutions: 2017. St. Louis: Institute for Public Health, Washington University; 2017.
Metadata
Title
Cancer incidence and mortality rates and trends in Trinidad and Tobago
Authors
Wayne A. Warner
Tammy Y. Lee
Kimberly Badal
Tanisha M. Williams
Smriti Bajracharya
Vasavi Sundaram
Nigel A. Bascombe
Ravi Maharaj
Marjorie Lamont-Greene
Allana Roach
Melissa Bondy
Matthew J. Ellis
Timothy R. Rebbeck
Simeon Slovacek
Jingqin Luo
Adetunji T. Toriola
Adana A. M. Llanos
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4625-x

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue

Research article

Activation of antioxidant defences of human mammary epithelial cells under leptin depend on neoplastic state

Research article

Validation of Quality of Life Instruments for Cancer Patients – Colorectal Cancer (QLICP-CR) in patients with colorectal cancer in Northeast China

Research article

Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma

Research article

Prediction of three lipid derivatives for postoperative gastric cancer mortality: the Fujian prospective investigation of cancer (FIESTA) study

Study protocol

Protocol for the “Chemobrain in Motion – study” (CIM – study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy

Research article

Changes in ovarian cancer survival during the 20 years before the era of targeted therapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits